id	sid	tid	token	lemma	pos
dpc-3912	1	1	dermatology	dermatology	NOUN
dpc-3912	1	2	:	:	PUNCT
dpc-3912	1	3	practical	practical	ADJ
dpc-3912	1	4	and	and	CCONJ
dpc-3912	1	5	conceptual	conceptual	ADJ
dpc-3912	1	6	research	research	NOUN
dpc-3912	1	7	letter	letter	NOUN
dpc-3912	2	1	|	|	ADV
dpc-3912	2	2	dermatol	dermatol	ADJ
dpc-3912	2	3	pract	pract	NOUN
dpc-3912	2	4	concept	concept	NOUN
dpc-3912	2	5	.	.	PUNCT
dpc-3912	3	1	2024;14(3):e2024161	2024;14(3):e2024161	NUM
dpc-3912	3	2	1	1	NUM
dpc-3912	3	3	folliculitis	folliculitis	NOUN
dpc-3912	3	4	decalvans	decalvan	NOUN
dpc-3912	3	5	due	due	ADJ
dpc-3912	3	6	to	to	ADP
dpc-3912	3	7	epidermal	epidermal	ADJ
dpc-3912	3	8	growth	growth	NOUN
dpc-3912	3	9	factor	factor	NOUN
dpc-3912	3	10	inhibitor	inhibitor	PROPN
dpc-3912	3	11	aurora	aurora	PROPN
dpc-3912	3	12	maria	maria	PROPN
dpc-3912	3	13	alessandrini2	alessandrini2	PROPN
dpc-3912	3	14	,	,	PUNCT
dpc-3912	3	15	alice	alice	PROPN
dpc-3912	3	16	nadia	nadia	PROPN
dpc-3912	3	17	rossi2	rossi2	PROPN
dpc-3912	3	18	,	,	PUNCT
dpc-3912	3	19	emi	emi	PROPN
dpc-3912	3	20	dika1,2	dika1,2	PROPN
dpc-3912	3	21	1	1	NUM
dpc-3912	3	22	irccs	irccs	NOUN
dpc-3912	3	23	azienda	azienda	PROPN
dpc-3912	3	24	ospedaliero	ospedaliero	PROPN
dpc-3912	3	25	-	-	PUNCT
dpc-3912	3	26	universitaria	universitaria	PROPN
dpc-3912	3	27	di	di	PROPN
dpc-3912	3	28	bologna	bologna	PROPN
dpc-3912	3	29	,	,	PUNCT
dpc-3912	3	30	bologna	bologna	PROPN
dpc-3912	3	31	,	,	PUNCT
dpc-3912	3	32	italy	italy	PROPN
dpc-3912	3	33	2	2	NUM
dpc-3912	3	34	dermatology	dermatology	NOUN
dpc-3912	3	35	,	,	PUNCT
dpc-3912	3	36	department	department	NOUN
dpc-3912	3	37	of	of	ADP
dpc-3912	3	38	medical	medical	ADJ
dpc-3912	3	39	and	and	CCONJ
dpc-3912	3	40	surgical	surgical	ADJ
dpc-3912	3	41	sciences	science	NOUN
dpc-3912	3	42	(	(	PUNCT
dpc-3912	3	43	dimec	dimec	PROPN
dpc-3912	3	44	)	)	PUNCT
dpc-3912	3	45	,	,	PUNCT
dpc-3912	3	46	alma	alma	NOUN
dpc-3912	3	47	mater	mater	PROPN
dpc-3912	3	48	studiorum	studiorum	PROPN
dpc-3912	3	49	,	,	PUNCT
dpc-3912	3	50	university	university	NOUN
dpc-3912	3	51	of	of	ADP
dpc-3912	3	52	bologna	bologna	NOUN
dpc-3912	3	53	,	,	PUNCT
dpc-3912	3	54	bologna	bologna	PROPN
dpc-3912	3	55	,	,	PUNCT
dpc-3912	3	56	italy	italy	PROPN
dpc-3912	3	57	key	key	ADJ
dpc-3912	3	58	words	word	NOUN
dpc-3912	3	59	:	:	PUNCT
dpc-3912	3	60	folliculitis	folliculitis	NOUN
dpc-3912	3	61	decalvans	decalvan	NOUN
dpc-3912	3	62	,	,	PUNCT
dpc-3912	3	63	dermatologic	dermatologic	ADJ
dpc-3912	3	64	drug	drug	NOUN
dpc-3912	3	65	adverse	adverse	ADJ
dpc-3912	3	66	effects	effect	NOUN
dpc-3912	3	67	,	,	PUNCT
dpc-3912	3	68	egfr	egfr	ADJ
dpc-3912	3	69	inhibitors	inhibitor	NOUN
dpc-3912	3	70	,	,	PUNCT
dpc-3912	3	71	trichology	trichology	NOUN
dpc-3912	3	72	citation	citation	NOUN
dpc-3912	3	73	:	:	PUNCT
dpc-3912	3	74	alessandrini	alessandrini	PROPN
dpc-3912	3	75	am	be	AUX
dpc-3912	3	76	,	,	PUNCT
dpc-3912	3	77	rossi	rossi	ADJ
dpc-3912	3	78	an	an	DET
dpc-3912	3	79	,	,	PUNCT
dpc-3912	3	80	dika	dika	NOUN
dpc-3912	3	81	e.	e.	PROPN
dpc-3912	3	82	folliculitis	folliculitis	PROPN
dpc-3912	3	83	decalvans	decalvan	VERB
dpc-3912	3	84	due	due	ADJ
dpc-3912	3	85	to	to	ADP
dpc-3912	3	86	epidermal	epidermal	ADJ
dpc-3912	3	87	growth	growth	NOUN
dpc-3912	3	88	factor	factor	NOUN
dpc-3912	3	89	inhibitor	inhibitor	NOUN
dpc-3912	3	90	.	.	PUNCT
dpc-3912	4	1	dermatol	dermatol	NOUN
dpc-3912	4	2	pract	pract	PROPN
dpc-3912	4	3	concept	concept	NOUN
dpc-3912	4	4	.	.	PUNCT
dpc-3912	5	1	2024;14(3):e2024161	2024;14(3):e2024161	X
dpc-3912	5	2	.	.	PUNCT
dpc-3912	5	3	doi	doi	NOUN
dpc-3912	5	4	:	:	PUNCT
dpc-3912	5	5	https://doi.org/10.5826/dpc.1403a161	https://doi.org/10.5826/dpc.1403a161	PROPN
dpc-3912	5	6	accepted	accept	VERB
dpc-3912	5	7	:	:	PUNCT
dpc-3912	5	8	february	february	PROPN
dpc-3912	5	9	27	27	NUM
dpc-3912	5	10	,	,	PUNCT
dpc-3912	5	11	2024	2024	NUM
dpc-3912	5	12	;	;	PUNCT
dpc-3912	5	13	published	publish	VERB
dpc-3912	5	14	:	:	PUNCT
dpc-3912	6	1	july	july	PROPN
dpc-3912	6	2	2024	2024	NUM
dpc-3912	6	3	copyright	copyright	NOUN
dpc-3912	6	4	:	:	PUNCT
dpc-3912	6	5	©	©	PROPN
dpc-3912	6	6	2024	2024	NUM
dpc-3912	6	7	alessandrini	alessandrini	PROPN
dpc-3912	6	8	et	et	PROPN
dpc-3912	6	9	al	al	PROPN
dpc-3912	6	10	.	.	PUNCT
dpc-3912	7	1	this	this	PRON
dpc-3912	7	2	is	be	AUX
dpc-3912	7	3	an	an	DET
dpc-3912	7	4	open	open	ADJ
dpc-3912	7	5	-	-	PUNCT
dpc-3912	7	6	access	access	NOUN
dpc-3912	7	7	article	article	NOUN
dpc-3912	7	8	distributed	distribute	VERB
dpc-3912	7	9	under	under	ADP
dpc-3912	7	10	the	the	DET
dpc-3912	7	11	terms	term	NOUN
dpc-3912	7	12	of	of	ADP
dpc-3912	7	13	the	the	DET
dpc-3912	7	14	creative	creative	ADJ
dpc-3912	7	15	commons	common	NOUN
dpc-3912	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3912	7	17	license	license	NOUN
dpc-3912	7	18	(	(	PUNCT
dpc-3912	7	19	by	by	ADP
dpc-3912	7	20	-	-	PUNCT
dpc-3912	7	21	nc-4.0	nc-4.0	NOUN
dpc-3912	7	22	)	)	PUNCT
dpc-3912	7	23	,	,	PUNCT
dpc-3912	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3912	7	25	,	,	PUNCT
dpc-3912	7	26	which	which	PRON
dpc-3912	7	27	permits	permit	VERB
dpc-3912	7	28	unrestricted	unrestricted	ADJ
dpc-3912	7	29	noncommercial	noncommercial	ADJ
dpc-3912	7	30	use	use	NOUN
dpc-3912	7	31	,	,	PUNCT
dpc-3912	7	32	distribution	distribution	NOUN
dpc-3912	7	33	,	,	PUNCT
dpc-3912	7	34	and	and	CCONJ
dpc-3912	7	35	reproduction	reproduction	NOUN
dpc-3912	7	36	in	in	ADP
dpc-3912	7	37	any	any	DET
dpc-3912	7	38	medium	medium	NOUN
dpc-3912	7	39	,	,	PUNCT
dpc-3912	7	40	provided	provide	VERB
dpc-3912	7	41	the	the	DET
dpc-3912	7	42	original	original	ADJ
dpc-3912	7	43	authors	author	NOUN
dpc-3912	7	44	and	and	CCONJ
dpc-3912	7	45	source	source	NOUN
dpc-3912	7	46	are	be	AUX
dpc-3912	7	47	credited	credit	VERB
dpc-3912	7	48	.	.	PUNCT
dpc-3912	8	1	funding	funding	NOUN
dpc-3912	8	2	:	:	PUNCT
dpc-3912	8	3	none	none	NOUN
dpc-3912	8	4	.	.	PUNCT
dpc-3912	9	1	competing	compete	VERB
dpc-3912	9	2	interests	interest	NOUN
dpc-3912	9	3	:	:	PUNCT
dpc-3912	9	4	none	none	NOUN
dpc-3912	9	5	.	.	PUNCT
dpc-3912	10	1	authorship	authorship	NOUN
dpc-3912	10	2	:	:	PUNCT
dpc-3912	10	3	all	all	DET
dpc-3912	10	4	authors	author	NOUN
dpc-3912	10	5	have	have	AUX
dpc-3912	10	6	contributed	contribute	VERB
dpc-3912	10	7	significantly	significantly	ADV
dpc-3912	10	8	to	to	ADP
dpc-3912	10	9	this	this	DET
dpc-3912	10	10	publication	publication	NOUN
dpc-3912	10	11	.	.	PUNCT
dpc-3912	11	1	corresponding	correspond	VERB
dpc-3912	11	2	author	author	NOUN
dpc-3912	11	3	:	:	PUNCT
dpc-3912	11	4	alice	alice	PROPN
dpc-3912	11	5	nadia	nadia	PROPN
dpc-3912	11	6	rossi	rossi	PROPN
dpc-3912	11	7	md	md	PROPN
dpc-3912	11	8	,	,	PUNCT
dpc-3912	11	9	dermatology	dermatology	NOUN
dpc-3912	11	10	,	,	PUNCT
dpc-3912	11	11	department	department	NOUN
dpc-3912	11	12	of	of	ADP
dpc-3912	11	13	medical	medical	ADJ
dpc-3912	11	14	and	and	CCONJ
dpc-3912	11	15	surgical	surgical	ADJ
dpc-3912	11	16	sciences	science	NOUN
dpc-3912	11	17	(	(	PUNCT
dpc-3912	11	18	dimec	dimec	PROPN
dpc-3912	11	19	)	)	PUNCT
dpc-3912	11	20	,	,	PUNCT
dpc-3912	11	21	alma	alma	NOUN
dpc-3912	11	22	mater	mater	PROPN
dpc-3912	11	23	studiorum	studiorum	PROPN
dpc-3912	11	24	,	,	PUNCT
dpc-3912	11	25	university	university	NOUN
dpc-3912	11	26	of	of	ADP
dpc-3912	11	27	bologna	bologna	NOUN
dpc-3912	11	28	,	,	PUNCT
dpc-3912	11	29	via	via	ADP
dpc-3912	11	30	massarenti	massarenti	NOUN
dpc-3912	11	31	9	9	NUM
dpc-3912	11	32	,	,	PUNCT
dpc-3912	11	33	40138	40138	NUM
dpc-3912	11	34	bologna	bologna	PROPN
dpc-3912	11	35	,	,	PUNCT
dpc-3912	11	36	italy	italy	PROPN
dpc-3912	11	37	.	.	PUNCT
dpc-3912	12	1	telephone	telephone	NOUN
dpc-3912	12	2	/	/	SYM
dpc-3912	12	3	fax	fax	NOUN
dpc-3912	12	4	:	:	PUNCT
dpc-3912	12	5	051	051	NUM
dpc-3912	12	6	214	214	NUM
dpc-3912	12	7	4844	4844	NUM
dpc-3912	12	8	.	.	PUNCT
dpc-3912	13	1	email	email	NOUN
dpc-3912	13	2	:	:	PUNCT
dpc-3912	13	3	alicenadia.rossi@studio	alicenadia.rossi@studio	NUM
dpc-3912	13	4	.	.	PUNCT
dpc-3912	14	1	unibo.it	unibo.it	NUM
dpc-3912	14	2	ethics	ethic	NOUN
dpc-3912	14	3	statement	statement	NOUN
dpc-3912	14	4	:	:	PUNCT
dpc-3912	14	5	the	the	DET
dpc-3912	14	6	patients	patient	NOUN
dpc-3912	14	7	in	in	ADP
dpc-3912	14	8	this	this	DET
dpc-3912	14	9	manuscript	manuscript	NOUN
dpc-3912	14	10	have	have	AUX
dpc-3912	14	11	given	give	VERB
dpc-3912	14	12	written	write	VERB
dpc-3912	14	13	informed	inform	VERB
dpc-3912	14	14	consent	consent	NOUN
dpc-3912	14	15	for	for	ADP
dpc-3912	14	16	the	the	DET
dpc-3912	14	17	publication	publication	NOUN
dpc-3912	14	18	of	of	ADP
dpc-3912	14	19	their	their	PRON
dpc-3912	14	20	case	case	NOUN
dpc-3912	14	21	details	detail	NOUN
dpc-3912	14	22	.	.	PUNCT
dpc-3912	15	1	introduction	introduction	NOUN
dpc-3912	15	2	folliculitis	folliculitis	PROPN
dpc-3912	15	3	decalvans	decalvan	NOUN
dpc-3912	15	4	is	be	AUX
dpc-3912	15	5	a	a	DET
dpc-3912	15	6	form	form	NOUN
dpc-3912	15	7	of	of	ADP
dpc-3912	15	8	recurrent	recurrent	ADJ
dpc-3912	15	9	painful	painful	ADJ
dpc-3912	15	10	scalp	scalp	NOUN
dpc-3912	15	11	folliculitis	folliculitis	NOUN
dpc-3912	15	12	causing	cause	VERB
dpc-3912	15	13	scarring	scar	VERB
dpc-3912	15	14	alopecia	alopecia	NOUN
dpc-3912	15	15	.	.	PUNCT
dpc-3912	16	1	the	the	DET
dpc-3912	16	2	etiology	etiology	NOUN
dpc-3912	16	3	is	be	AUX
dpc-3912	16	4	unclear	unclear	ADJ
dpc-3912	16	5	,	,	PUNCT
dpc-3912	16	6	although	although	SCONJ
dpc-3912	16	7	staphylococcus	staphylococcus	NOUN
dpc-3912	16	8	aureus	aureus	NOUN
dpc-3912	16	9	appears	appear	VERB
dpc-3912	16	10	to	to	PART
dpc-3912	16	11	play	play	VERB
dpc-3912	16	12	a	a	DET
dpc-3912	16	13	role	role	NOUN
dpc-3912	16	14	in	in	ADP
dpc-3912	16	15	its	its	PRON
dpc-3912	16	16	pathogenesis	pathogenesis	NOUN
dpc-3912	16	17	.	.	PUNCT
dpc-3912	17	1	it	it	PRON
dpc-3912	17	2	predominantly	predominantly	ADV
dpc-3912	17	3	affects	affect	VERB
dpc-3912	17	4	the	the	DET
dpc-3912	17	5	vertex	vertex	NOUN
dpc-3912	17	6	and	and	CCONJ
dpc-3912	17	7	occipital	occipital	NOUN
dpc-3912	17	8	areas	area	NOUN
dpc-3912	17	9	,	,	PUNCT
dpc-3912	17	10	starting	start	VERB
dpc-3912	17	11	as	as	ADP
dpc-3912	17	12	erythematous	erythematous	ADJ
dpc-3912	17	13	follicular	follicular	ADJ
dpc-3912	17	14	papules	papule	NOUN
dpc-3912	17	15	and	and	CCONJ
dpc-3912	17	16	progressing	progress	VERB
dpc-3912	17	17	to	to	ADP
dpc-3912	17	18	pustules	pustule	NOUN
dpc-3912	17	19	and	and	CCONJ
dpc-3912	17	20	scarring	scarring	NOUN
dpc-3912	17	21	.	.	PUNCT
dpc-3912	18	1	symptoms	symptom	NOUN
dpc-3912	18	2	include	include	VERB
dpc-3912	18	3	pain	pain	NOUN
dpc-3912	18	4	,	,	PUNCT
dpc-3912	18	5	pruritus	pruritus	NOUN
dpc-3912	18	6	and	and	CCONJ
dpc-3912	18	7	burning	burning	NOUN
dpc-3912	18	8	.	.	PUNCT
dpc-3912	19	1	diagnosis	diagnosis	NOUN
dpc-3912	19	2	includes	include	VERB
dpc-3912	19	3	clinical	clinical	ADJ
dpc-3912	19	4	examination	examination	NOUN
dpc-3912	19	5	and	and	CCONJ
dpc-3912	19	6	trichoscopy	trichoscopy	NOUN
dpc-3912	19	7	showing	show	VERB
dpc-3912	19	8	tufted	tufted	ADJ
dpc-3912	19	9	hairs	hair	NOUN
dpc-3912	19	10	,	,	PUNCT
dpc-3912	19	11	perifollicular	perifollicular	PROPN
dpc-3912	19	12	erythema	erythema	ADJ
dpc-3912	19	13	,	,	PUNCT
dpc-3912	19	14	scaling	scaling	NOUN
dpc-3912	19	15	,	,	PUNCT
dpc-3912	19	16	pustules	pustule	NOUN
dpc-3912	19	17	and	and	CCONJ
dpc-3912	19	18	hemorrhagic	hemorrhagic	NOUN
dpc-3912	19	19	crusts	crust	NOUN
dpc-3912	19	20	.	.	PUNCT
dpc-3912	20	1	in	in	ADP
dpc-3912	20	2	long	long	ADV
dpc-3912	20	3	-	-	PUNCT
dpc-3912	20	4	standing	stand	VERB
dpc-3912	20	5	lesions	lesion	NOUN
dpc-3912	20	6	,	,	PUNCT
dpc-3912	20	7	white	white	ADJ
dpc-3912	20	8	and	and	CCONJ
dpc-3912	20	9	milky	milky	ADJ
dpc-3912	20	10	red	red	ADJ
dpc-3912	20	11	areas	area	NOUN
dpc-3912	20	12	without	without	ADP
dpc-3912	20	13	follicular	follicular	ADJ
dpc-3912	20	14	openings	opening	NOUN
dpc-3912	20	15	predominate	predominate	VERB
dpc-3912	20	16	[	[	X
dpc-3912	20	17	1	1	NUM
dpc-3912	20	18	]	]	PUNCT
dpc-3912	20	19	.	.	PUNCT
dpc-3912	21	1	skin	skin	NOUN
dpc-3912	21	2	biopsy	biopsy	NOUN
dpc-3912	21	3	is	be	AUX
dpc-3912	21	4	required	require	VERB
dpc-3912	21	5	to	to	PART
dpc-3912	21	6	confirm	confirm	VERB
dpc-3912	21	7	the	the	DET
dpc-3912	21	8	diagnosis	diagnosis	NOUN
dpc-3912	21	9	.	.	PUNCT
dpc-3912	22	1	treatment	treatment	NOUN
dpc-3912	22	2	involves	involve	VERB
dpc-3912	22	3	a	a	DET
dpc-3912	22	4	combination	combination	NOUN
dpc-3912	22	5	of	of	ADP
dpc-3912	22	6	oral	oral	ADJ
dpc-3912	22	7	and	and	CCONJ
dpc-3912	22	8	topical	topical	ADJ
dpc-3912	22	9	antibiotics	antibiotic	NOUN
dpc-3912	22	10	and	and	CCONJ
dpc-3912	22	11	corticosteroids	corticosteroid	NOUN
dpc-3912	22	12	.	.	PUNCT
dpc-3912	23	1	isotretinoin	isotretinoin	PROPN
dpc-3912	23	2	and	and	CCONJ
dpc-3912	23	3	dapsone	dapsone	PROPN
dpc-3912	23	4	have	have	AUX
dpc-3912	23	5	also	also	ADV
dpc-3912	23	6	been	be	AUX
dpc-3912	23	7	reported	report	VERB
dpc-3912	23	8	as	as	ADP
dpc-3912	23	9	therapeutic	therapeutic	ADJ
dpc-3912	23	10	options	option	NOUN
dpc-3912	23	11	[	[	X
dpc-3912	23	12	2	2	NUM
dpc-3912	23	13	]	]	PUNCT
dpc-3912	23	14	.	.	PUNCT
dpc-3912	24	1	folliculitis	folliculitis	PROPN
dpc-3912	24	2	decalvans	decalvan	NOUN
dpc-3912	24	3	could	could	AUX
dpc-3912	24	4	be	be	AUX
dpc-3912	24	5	a	a	DET
dpc-3912	24	6	rare	rare	ADJ
dpc-3912	24	7	adverse	adverse	ADJ
dpc-3912	24	8	effect	effect	NOUN
dpc-3912	24	9	of	of	ADP
dpc-3912	24	10	epidermal	epidermal	ADJ
dpc-3912	24	11	growth	growth	NOUN
dpc-3912	24	12	factor	factor	NOUN
dpc-3912	24	13	receptor	receptor	NOUN
dpc-3912	24	14	(	(	PUNCT
dpc-3912	24	15	egfr	egfr	X
dpc-3912	24	16	)	)	PUNCT
dpc-3912	24	17	inhibitors	inhibitor	NOUN
dpc-3912	24	18	that	that	PRON
dpc-3912	24	19	is	be	AUX
dpc-3912	24	20	responsible	responsible	ADJ
dpc-3912	24	21	for	for	ADP
dpc-3912	24	22	cutaneous	cutaneous	ADJ
dpc-3912	24	23	adverse	adverse	ADJ
dpc-3912	24	24	events	event	NOUN
dpc-3912	24	25	in	in	ADP
dpc-3912	24	26	75	75	NUM
dpc-3912	24	27	%	%	NOUN
dpc-3912	24	28	to	to	PART
dpc-3912	24	29	90	90	NUM
dpc-3912	24	30	%	%	NOUN
dpc-3912	24	31	of	of	ADP
dpc-3912	24	32	patients	patient	NOUN
dpc-3912	24	33	[	[	X
dpc-3912	24	34	3	3	NUM
dpc-3912	24	35	]	]	PUNCT
dpc-3912	24	36	.	.	PUNCT
dpc-3912	25	1	the	the	DET
dpc-3912	25	2	most	most	ADV
dpc-3912	25	3	common	common	ADJ
dpc-3912	25	4	include	include	VERB
dpc-3912	25	5	papulopustular	papulopustular	ADJ
dpc-3912	25	6	and	and	CCONJ
dpc-3912	25	7	acneiform	acneiform	ADJ
dpc-3912	25	8	eruptions	eruption	NOUN
dpc-3912	25	9	,	,	PUNCT
dpc-3912	25	10	xerosis	xerosis	NOUN
dpc-3912	25	11	,	,	PUNCT
dpc-3912	25	12	seborrhoeic	seborrhoeic	PROPN
dpc-3912	25	13	dermatitis	dermatitis	NOUN
dpc-3912	25	14	,	,	PUNCT
dpc-3912	25	15	chronic	chronic	NOUN
dpc-3912	25	16	paronychia	paronychia	VERB
dpc-3912	25	17	and	and	CCONJ
dpc-3912	25	18	changes	change	NOUN
dpc-3912	25	19	in	in	ADP
dpc-3912	25	20	hair	hair	NOUN
dpc-3912	25	21	texture	texture	NOUN
dpc-3912	25	22	.	.	PUNCT
dpc-3912	26	1	only	only	ADV
dpc-3912	26	2	a	a	DET
dpc-3912	26	3	few	few	ADJ
dpc-3912	26	4	cases	case	NOUN
dpc-3912	26	5	of	of	ADP
dpc-3912	26	6	egfr	egfr	ADJ
dpc-3912	26	7	inhibitor	inhibitor	NOUN
dpc-3912	26	8	-	-	PUNCT
dpc-3912	26	9	associated	associate	VERB
dpc-3912	26	10	folliculitis	folliculitis	NOUN
dpc-3912	26	11	decalvans	decalvan	NOUN
dpc-3912	26	12	have	have	AUX
dpc-3912	26	13	been	be	AUX
dpc-3912	26	14	described	describe	VERB
dpc-3912	26	15	in	in	ADP
dpc-3912	26	16	the	the	DET
dpc-3912	26	17	literature	literature	NOUN
dpc-3912	26	18	,	,	PUNCT
dpc-3912	26	19	mainly	mainly	ADV
dpc-3912	26	20	related	relate	VERB
dpc-3912	26	21	to	to	PART
dpc-3912	26	22	erlotinib	erlotinib	NOUN
dpc-3912	26	23	[	[	X
dpc-3912	26	24	4	4	NUM
dpc-3912	26	25	]	]	PUNCT
dpc-3912	26	26	,	,	PUNCT
dpc-3912	26	27	while	while	SCONJ
dpc-3912	26	28	knowledge	knowledge	NOUN
dpc-3912	26	29	about	about	ADP
dpc-3912	26	30	osimertinib	osimertinib	NOUN
dpc-3912	26	31	is	be	AUX
dpc-3912	26	32	limited	limit	VERB
dpc-3912	26	33	.	.	PUNCT
dpc-3912	27	1	osimertinib	osimertinib	NOUN
dpc-3912	27	2	is	be	AUX
dpc-3912	27	3	a	a	DET
dpc-3912	27	4	third	third	ADJ
dpc-3912	27	5	-	-	PUNCT
dpc-3912	27	6	generation	generation	NOUN
dpc-3912	27	7	egfr	egfr	ADJ
dpc-3912	27	8	inhibitor	inhibitor	NOUN
dpc-3912	27	9	approved	approve	VERB
dpc-3912	27	10	for	for	ADP
dpc-3912	27	11	the	the	DET
dpc-3912	27	12	firstline	firstline	ADJ
dpc-3912	27	13	treatment	treatment	NOUN
dpc-3912	27	14	of	of	ADP
dpc-3912	27	15	patients	patient	NOUN
dpc-3912	27	16	with	with	ADP
dpc-3912	27	17	metastatic	metastatic	ADJ
dpc-3912	27	18	non	non	ADJ
dpc-3912	27	19	-	-	ADJ
dpc-3912	27	20	small	small	ADJ
dpc-3912	27	21	cell	cell	NOUN
dpc-3912	27	22	lung	lung	NOUN
dpc-3912	27	23	cancer	cancer	NOUN
dpc-3912	27	24	(	(	PUNCT
dpc-3912	27	25	nsclc	nsclc	NOUN
dpc-3912	27	26	)	)	PUNCT
dpc-3912	27	27	with	with	ADP
dpc-3912	27	28	egfr	egfr	ADJ
dpc-3912	27	29	mutations	mutation	NOUN
dpc-3912	27	30	[	[	X
dpc-3912	27	31	5	5	NUM
dpc-3912	27	32	]	]	PUNCT
dpc-3912	27	33	.	.	PUNCT
dpc-3912	28	1	the	the	DET
dpc-3912	28	2	mechanisms	mechanism	NOUN
dpc-3912	28	3	behind	behind	ADP
dpc-3912	28	4	egfr	egfr	ADJ
dpc-3912	28	5	inhibitors	inhibitor	NOUN
dpc-3912	28	6	-	-	PUNCT
dpc-3912	28	7	induced	induce	VERB
dpc-3912	28	8	scalp	scalp	NOUN
dpc-3912	28	9	toxicity	toxicity	NOUN
dpc-3912	28	10	are	be	AUX
dpc-3912	28	11	still	still	ADV
dpc-3912	28	12	unclear	unclear	ADJ
dpc-3912	28	13	.	.	PUNCT
dpc-3912	29	1	egfr	egfr	PROPN
dpc-3912	29	2	is	be	AUX
dpc-3912	29	3	involved	involve	VERB
dpc-3912	29	4	in	in	ADP
dpc-3912	29	5	keratinisation	keratinisation	NOUN
dpc-3912	29	6	and	and	CCONJ
dpc-3912	29	7	regulation	regulation	NOUN
dpc-3912	29	8	of	of	ADP
dpc-3912	29	9	the	the	DET
dpc-3912	29	10	hair	hair	NOUN
dpc-3912	29	11	growth	growth	NOUN
dpc-3912	29	12	cycle	cycle	NOUN
dpc-3912	29	13	.	.	PUNCT
dpc-3912	30	1	it	it	PRON
dpc-3912	30	2	is	be	AUX
dpc-3912	30	3	highly	highly	ADV
dpc-3912	30	4	expressed	express	VERB
dpc-3912	30	5	in	in	ADP
dpc-3912	30	6	basal	basal	ADJ
dpc-3912	30	7	keratinocytes	keratinocyte	NOUN
dpc-3912	30	8	,	,	PUNCT
dpc-3912	30	9	sebaceous	sebaceous	ADJ
dpc-3912	30	10	and	and	CCONJ
dpc-3912	30	11	eccrine	eccrine	ADJ
dpc-3912	30	12	glands	gland	NOUN
dpc-3912	30	13	,	,	PUNCT
dpc-3912	30	14	and	and	CCONJ
dpc-3912	30	15	in	in	ADP
dpc-3912	30	16	the	the	DET
dpc-3912	30	17	outer	outer	ADJ
dpc-3912	30	18	root	root	NOUN
dpc-3912	30	19	sheath	sheath	NOUN
dpc-3912	30	20	of	of	ADP
dpc-3912	30	21	hair	hair	NOUN
dpc-3912	30	22	follicles	follicle	NOUN
dpc-3912	30	23	.	.	PUNCT
dpc-3912	31	1	egfr	egfr	ADJ
dpc-3912	31	2	inhibition	inhibition	NOUN
dpc-3912	31	3	causes	cause	VERB
dpc-3912	31	4	defects	defect	NOUN
dpc-3912	31	5	in	in	ADP
dpc-3912	31	6	the	the	DET
dpc-3912	31	7	anagen	anagen	NOUN
dpc-3912	31	8	-	-	PUNCT
dpc-3912	31	9	catagen	catagen	NOUN
dpc-3912	31	10	transition	transition	NOUN
dpc-3912	31	11	along	along	ADP
dpc-3912	31	12	with	with	ADP
dpc-3912	31	13	a	a	DET
dpc-3912	31	14	significant	significant	ADJ
dpc-3912	31	15	inflammatory	inflammatory	ADJ
dpc-3912	31	16	response	response	NOUN
dpc-3912	31	17	,	,	PUNCT
dpc-3912	31	18	resulting	result	VERB
dpc-3912	31	19	in	in	ADP
dpc-3912	31	20	hair	hair	NOUN
dpc-3912	31	21	follicle	follicle	NOUN
dpc-3912	31	22	necrosis	necrosis	NOUN
dpc-3912	31	23	and	and	CCONJ
dpc-3912	31	24	destruction	destruction	NOUN
dpc-3912	31	25	[	[	X
dpc-3912	31	26	6	6	NUM
dpc-3912	31	27	]	]	PUNCT
dpc-3912	31	28	.	.	PUNCT
dpc-3912	32	1	our	our	PRON
dpc-3912	32	2	case	case	NOUN
dpc-3912	32	3	shows	show	VERB
dpc-3912	32	4	that	that	SCONJ
dpc-3912	32	5	osimertinib	osimertinib	NOUN
dpc-3912	32	6	,	,	PUNCT
dpc-3912	32	7	along	along	ADP
dpc-3912	32	8	with	with	ADP
dpc-3912	32	9	other	other	ADJ
dpc-3912	32	10	egfr	egfr	ADJ
dpc-3912	32	11	inhibitors	inhibitor	NOUN
dpc-3912	32	12	,	,	PUNCT
dpc-3912	32	13	may	may	AUX
dpc-3912	32	14	cause	cause	VERB
dpc-3912	32	15	treatment	treatment	NOUN
dpc-3912	32	16	-	-	PUNCT
dpc-3912	32	17	induced	induce	VERB
dpc-3912	32	18	folliculitis	folliculitis	NOUN
dpc-3912	32	19	decalvans	decalvan	NOUN
dpc-3912	32	20	.	.	PUNCT
dpc-3912	33	1	2	2	NUM
dpc-3912	33	2	research	research	NOUN
dpc-3912	33	3	letter	letter	NOUN
dpc-3912	33	4	|	|	ADV
dpc-3912	33	5	dermatol	dermatol	ADJ
dpc-3912	33	6	pract	pract	NOUN
dpc-3912	33	7	concept	concept	NOUN
dpc-3912	33	8	.	.	PUNCT
dpc-3912	34	1	2024;14(3):e2024161	2024;14(3):e2024161	NUM
dpc-3912	34	2	case	case	NOUN
dpc-3912	34	3	presentation	presentation	NOUN
dpc-3912	34	4	we	we	PRON
dpc-3912	34	5	report	report	VERB
dpc-3912	34	6	a	a	DET
dpc-3912	34	7	case	case	NOUN
dpc-3912	34	8	of	of	ADP
dpc-3912	34	9	osimertinib	osimertinib	NOUN
dpc-3912	34	10	-	-	PUNCT
dpc-3912	34	11	induced	induce	VERB
dpc-3912	34	12	folliculitis	folliculitis	NOUN
dpc-3912	34	13	decalvans	decalvan	NOUN
dpc-3912	34	14	in	in	ADP
dpc-3912	34	15	a	a	DET
dpc-3912	34	16	middle	middle	ADJ
dpc-3912	34	17	-	-	PUNCT
dpc-3912	34	18	aged	aged	ADJ
dpc-3912	34	19	woman	woman	NOUN
dpc-3912	34	20	.	.	PUNCT
dpc-3912	35	1	cutaneous	cutaneous	ADJ
dpc-3912	35	2	adverse	adverse	ADJ
dpc-3912	35	3	effects	effect	NOUN
dpc-3912	35	4	have	have	AUX
dpc-3912	35	5	been	be	AUX
dpc-3912	35	6	frequently	frequently	ADV
dpc-3912	35	7	described	describe	VERB
dpc-3912	35	8	in	in	ADP
dpc-3912	35	9	association	association	NOUN
dpc-3912	35	10	with	with	ADP
dpc-3912	35	11	egfr	egfr	PROPN
dpc-3912	35	12	tyrosine	tyrosine	PROPN
dpc-3912	35	13	kinase	kinase	PROPN
dpc-3912	35	14	inhibitors	inhibitor	NOUN
dpc-3912	35	15	(	(	PUNCT
dpc-3912	35	16	tkis	tkis	NOUN
dpc-3912	35	17	)	)	PUNCT
dpc-3912	35	18	,	,	PUNCT
dpc-3912	35	19	particularly	particularly	ADV
dpc-3912	35	20	erlotinib	erlotinib	NOUN
dpc-3912	35	21	,	,	PUNCT
dpc-3912	35	22	but	but	CCONJ
dpc-3912	35	23	little	little	ADJ
dpc-3912	35	24	is	be	AUX
dpc-3912	35	25	known	know	VERB
dpc-3912	35	26	about	about	ADP
dpc-3912	35	27	osimertinib	osimertinib	NOUN
dpc-3912	35	28	.	.	PUNCT
dpc-3912	36	1	a	a	DET
dpc-3912	36	2	55	55	NUM
dpc-3912	36	3	-	-	PUNCT
dpc-3912	36	4	year	year	NOUN
dpc-3912	36	5	-	-	PUNCT
dpc-3912	36	6	old	old	ADJ
dpc-3912	36	7	female	female	ADJ
dpc-3912	36	8	patient	patient	NOUN
dpc-3912	36	9	was	be	AUX
dpc-3912	36	10	referred	refer	VERB
dpc-3912	36	11	to	to	ADP
dpc-3912	36	12	our	our	PRON
dpc-3912	36	13	department	department	NOUN
dpc-3912	36	14	for	for	ADP
dpc-3912	36	15	the	the	DET
dpc-3912	36	16	onset	onset	NOUN
dpc-3912	36	17	of	of	ADP
dpc-3912	36	18	scalp	scalp	NOUN
dpc-3912	36	19	symptoms	symptom	NOUN
dpc-3912	36	20	.	.	PUNCT
dpc-3912	37	1	she	she	PRON
dpc-3912	37	2	had	have	AUX
dpc-3912	37	3	been	be	AUX
dpc-3912	37	4	diagnosed	diagnose	VERB
dpc-3912	37	5	with	with	ADP
dpc-3912	37	6	stage	stage	NOUN
dpc-3912	37	7	iiic	iiic	PROPN
dpc-3912	37	8	egfr	egfr	ADJ
dpc-3912	37	9	-	-	PUNCT
dpc-3912	37	10	mutant	mutant	NOUN
dpc-3912	37	11	lung	lung	NOUN
dpc-3912	37	12	adenocarcinoma	adenocarcinoma	NOUN
dpc-3912	37	13	and	and	CCONJ
dpc-3912	37	14	was	be	AUX
dpc-3912	37	15	started	start	VERB
dpc-3912	37	16	on	on	ADP
dpc-3912	37	17	osimertinib	osimertinib	NOUN
dpc-3912	37	18	.	.	PUNCT
dpc-3912	38	1	during	during	ADP
dpc-3912	38	2	treatment	treatment	NOUN
dpc-3912	38	3	,	,	PUNCT
dpc-3912	38	4	the	the	DET
dpc-3912	38	5	patient	patient	NOUN
dpc-3912	38	6	developed	develop	VERB
dpc-3912	38	7	an	an	DET
dpc-3912	38	8	itchy	itchy	ADJ
dpc-3912	38	9	and	and	CCONJ
dpc-3912	38	10	crusty	crusty	ADJ
dpc-3912	38	11	scalp	scalp	NOUN
dpc-3912	38	12	eruption	eruption	NOUN
dpc-3912	38	13	.	.	PUNCT
dpc-3912	39	1	physical	physical	ADJ
dpc-3912	39	2	examination	examination	NOUN
dpc-3912	39	3	and	and	CCONJ
dpc-3912	39	4	trichoscopy	trichoscopy	NOUN
dpc-3912	39	5	showed	show	VERB
dpc-3912	39	6	erythematous	erythematous	ADJ
dpc-3912	39	7	and	and	CCONJ
dpc-3912	39	8	scaly	scaly	NOUN
dpc-3912	39	9	lesions	lesion	NOUN
dpc-3912	39	10	with	with	ADP
dpc-3912	39	11	pustules	pustule	NOUN
dpc-3912	39	12	,	,	PUNCT
dpc-3912	39	13	crusting	crust	VERB
dpc-3912	39	14	and	and	CCONJ
dpc-3912	39	15	scarring	scar	VERB
dpc-3912	39	16	along	along	ADP
dpc-3912	39	17	with	with	ADP
dpc-3912	39	18	the	the	DET
dpc-3912	39	19	characteristic	characteristic	ADJ
dpc-3912	39	20	tufted	tufte	VERB
dpc-3912	39	21	hairs	hair	NOUN
dpc-3912	39	22	(	(	PUNCT
dpc-3912	39	23	figure	figure	NOUN
dpc-3912	39	24	1	1	NUM
dpc-3912	39	25	)	)	PUNCT
dpc-3912	39	26	.	.	PUNCT
dpc-3912	40	1	a	a	DET
dpc-3912	40	2	punch	punch	NOUN
dpc-3912	40	3	biopsy	biopsy	NOUN
dpc-3912	40	4	was	be	AUX
dpc-3912	40	5	obtained	obtain	VERB
dpc-3912	40	6	:	:	PUNCT
dpc-3912	40	7	histopathological	histopathological	ADJ
dpc-3912	40	8	examination	examination	NOUN
dpc-3912	40	9	revealed	reveal	VERB
dpc-3912	40	10	reduced	reduce	VERB
dpc-3912	40	11	follicular	follicular	ADJ
dpc-3912	40	12	density	density	NOUN
dpc-3912	40	13	,	,	PUNCT
dpc-3912	40	14	loss	loss	NOUN
dpc-3912	40	15	of	of	ADP
dpc-3912	40	16	sebaceous	sebaceous	ADJ
dpc-3912	40	17	glands	gland	NOUN
dpc-3912	40	18	,	,	PUNCT
dpc-3912	40	19	oedema	oedema	NOUN
dpc-3912	40	20	,	,	PUNCT
dpc-3912	40	21	dilated	dilated	ADJ
dpc-3912	40	22	vessels	vessel	NOUN
dpc-3912	40	23	,	,	PUNCT
dpc-3912	40	24	a	a	DET
dpc-3912	40	25	dense	dense	ADJ
dpc-3912	40	26	follicular	follicular	ADJ
dpc-3912	40	27	and	and	CCONJ
dpc-3912	40	28	perivascular	perivascular	ADJ
dpc-3912	40	29	predominantly	predominantly	ADV
dpc-3912	40	30	neutrophilic	neutrophilic	ADJ
dpc-3912	40	31	infiltrate	infiltrate	ADJ
dpc-3912	40	32	and	and	CCONJ
dpc-3912	40	33	severe	severe	ADJ
dpc-3912	40	34	and	and	CCONJ
dpc-3912	40	35	extensive	extensive	ADJ
dpc-3912	40	36	fibrosis	fibrosis	NOUN
dpc-3912	40	37	(	(	PUNCT
dpc-3912	40	38	figure	figure	NOUN
dpc-3912	40	39	2	2	NUM
dpc-3912	40	40	)	)	PUNCT
dpc-3912	40	41	.	.	PUNCT
dpc-3912	41	1	these	these	DET
dpc-3912	41	2	findings	finding	NOUN
dpc-3912	41	3	were	be	AUX
dpc-3912	41	4	consistent	consistent	ADJ
dpc-3912	41	5	with	with	ADP
dpc-3912	41	6	a	a	DET
dpc-3912	41	7	diagnosis	diagnosis	NOUN
dpc-3912	41	8	of	of	ADP
dpc-3912	41	9	folliculitis	folliculitis	NOUN
dpc-3912	41	10	decalvans	decalvan	NOUN
dpc-3912	41	11	.	.	PUNCT
dpc-3912	42	1	the	the	DET
dpc-3912	42	2	condition	condition	NOUN
dpc-3912	42	3	was	be	AUX
dpc-3912	42	4	improved	improve	VERB
dpc-3912	42	5	by	by	ADP
dpc-3912	42	6	a	a	DET
dpc-3912	42	7	systemic	systemic	ADJ
dpc-3912	42	8	antibiotic	antibiotic	ADJ
dpc-3912	42	9	treatment	treatment	NOUN
dpc-3912	42	10	with	with	ADP
dpc-3912	42	11	doxycycline	doxycycline	NOUN
dpc-3912	42	12	100	100	NUM
dpc-3912	42	13	mg	mg	ADP
dpc-3912	42	14	twice	twice	ADV
dpc-3912	42	15	daily	daily	ADV
dpc-3912	42	16	for	for	ADP
dpc-3912	42	17	one	one	NUM
dpc-3912	42	18	month	month	NOUN
dpc-3912	42	19	,	,	PUNCT
dpc-3912	42	20	followed	follow	VERB
dpc-3912	42	21	by	by	ADP
dpc-3912	42	22	once	once	ADV
dpc-3912	42	23	daily	daily	ADV
dpc-3912	42	24	for	for	ADP
dpc-3912	42	25	three	three	NUM
dpc-3912	42	26	months	month	NOUN
dpc-3912	42	27	and	and	CCONJ
dpc-3912	42	28	topical	topical	ADJ
dpc-3912	42	29	steroids	steroid	NOUN
dpc-3912	42	30	.	.	PUNCT
dpc-3912	43	1	osimertinib	osimertinib	NOUN
dpc-3912	43	2	dosage	dosage	NOUN
dpc-3912	43	3	remained	remain	VERB
dpc-3912	43	4	unchanged	unchanged	ADJ
dpc-3912	43	5	.	.	PUNCT
dpc-3912	44	1	conclusions	conclusion	NOUN
dpc-3912	44	2	as	as	ADP
dpc-3912	44	3	the	the	DET
dpc-3912	44	4	use	use	NOUN
dpc-3912	44	5	of	of	ADP
dpc-3912	44	6	osimertinib	osimertinib	NOUN
dpc-3912	44	7	and	and	CCONJ
dpc-3912	44	8	other	other	ADJ
dpc-3912	44	9	egfr	egfr	ADJ
dpc-3912	44	10	inhibitors	inhibitor	NOUN
dpc-3912	44	11	increases	increase	NOUN
dpc-3912	44	12	,	,	PUNCT
dpc-3912	44	13	it	it	PRON
dpc-3912	44	14	is	be	AUX
dpc-3912	44	15	important	important	ADJ
dpc-3912	44	16	for	for	SCONJ
dpc-3912	44	17	dermatologists	dermatologist	NOUN
dpc-3912	44	18	to	to	PART
dpc-3912	44	19	be	be	AUX
dpc-3912	44	20	aware	aware	ADJ
dpc-3912	44	21	of	of	ADP
dpc-3912	44	22	their	their	PRON
dpc-3912	44	23	potential	potential	ADJ
dpc-3912	44	24	cutaneous	cutaneous	ADJ
dpc-3912	44	25	side	side	NOUN
dpc-3912	44	26	effects	effect	NOUN
dpc-3912	44	27	,	,	PUNCT
dpc-3912	44	28	including	include	VERB
dpc-3912	44	29	rare	rare	ADJ
dpc-3912	44	30	ones	one	NOUN
dpc-3912	44	31	such	such	ADJ
dpc-3912	44	32	as	as	ADP
dpc-3912	44	33	folliculitis	folliculitis	NOUN
dpc-3912	44	34	decalvans	decalvan	NOUN
dpc-3912	44	35	,	,	PUNCT
dpc-3912	44	36	to	to	PART
dpc-3912	44	37	enable	enable	VERB
dpc-3912	44	38	early	early	ADJ
dpc-3912	44	39	diagnosis	diagnosis	NOUN
dpc-3912	44	40	and	and	CCONJ
dpc-3912	44	41	treatment	treatment	NOUN
dpc-3912	44	42	and	and	CCONJ
dpc-3912	44	43	thus	thus	ADV
dpc-3912	44	44	prevent	prevent	VERB
dpc-3912	44	45	adverse	adverse	ADJ
dpc-3912	44	46	aesthetic	aesthetic	ADJ
dpc-3912	44	47	and	and	CCONJ
dpc-3912	44	48	functional	functional	ADJ
dpc-3912	44	49	outcomes	outcome	NOUN
dpc-3912	44	50	.	.	PUNCT
dpc-3912	45	1	references	reference	NOUN
dpc-3912	45	2	1	1	NUM
dpc-3912	45	3	.	.	PUNCT
dpc-3912	45	4	fernández	fernández	PROPN
dpc-3912	45	5	-	-	PUNCT
dpc-3912	45	6	domper	domper	PROPN
dpc-3912	45	7	l	l	NOUN
dpc-3912	45	8	,	,	PUNCT
dpc-3912	45	9	ballesteros	ballesteros	PROPN
dpc-3912	45	10	-	-	PUNCT
dpc-3912	45	11	redondo	redondo	PROPN
dpc-3912	45	12	m	m	PROPN
dpc-3912	45	13	,	,	PUNCT
dpc-3912	45	14	vañó	vañó	ADJ
dpc-3912	45	15	-	-	PUNCT
dpc-3912	45	16	galván	galván	NOUN
dpc-3912	45	17	s.	s.	PROPN
dpc-3912	45	18	trichoscopy	trichoscopy	PROPN
dpc-3912	45	19	:	:	PUNCT
dpc-3912	45	20	an	an	DET
dpc-3912	45	21	update	update	NOUN
dpc-3912	45	22	.	.	PUNCT
dpc-3912	46	1	actas	actas	PROPN
dpc-3912	46	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-3912	46	3	.	.	PUNCT
dpc-3912	47	1	2023;114(4	2023;114(4	NOUN
dpc-3912	47	2	):	):	PUNCT
dpc-3912	47	3	327	327	NUM
dpc-3912	47	4	-	-	SYM
dpc-3912	47	5	333	333	NUM
dpc-3912	47	6	.	.	PUNCT
dpc-3912	48	1	doi	doi	NOUN
dpc-3912	48	2	:	:	PUNCT
dpc-3912	48	3	10.1016	10.1016	NUM
dpc-3912	48	4	/	/	SYM
dpc-3912	48	5	j.ad.2022.12.003	j.ad.2022.12.003	PROPN
dpc-3912	48	6	.	.	PUNCT
dpc-3912	49	1	pmid	pmid	NOUN
dpc-3912	49	2	:	:	PUNCT
dpc-3912	49	3	36574917	36574917	NUM
dpc-3912	49	4	.	.	PUNCT
dpc-3912	50	1	2	2	NUM
dpc-3912	50	2	.	.	NOUN
dpc-3912	50	3	bardazzi	bardazzi	PROPN
dpc-3912	50	4	f	f	PROPN
dpc-3912	50	5	,	,	PUNCT
dpc-3912	50	6	savoia	savoia	PROPN
dpc-3912	50	7	f	f	PROPN
dpc-3912	50	8	,	,	PUNCT
dpc-3912	50	9	parente	parente	VERB
dpc-3912	50	10	g	g	PROPN
dpc-3912	50	11	,	,	PUNCT
dpc-3912	50	12	et	et	PROPN
dpc-3912	50	13	al	al	PROPN
dpc-3912	50	14	.	.	PROPN
dpc-3912	50	15	azithromycin	azithromycin	PROPN
dpc-3912	50	16	:	:	PUNCT
dpc-3912	50	17	a	a	DET
dpc-3912	50	18	new	new	ADJ
dpc-3912	50	19	therapeutical	therapeutical	ADJ
dpc-3912	50	20	strategy	strategy	NOUN
dpc-3912	50	21	for	for	ADP
dpc-3912	50	22	acne	acne	NOUN
dpc-3912	50	23	in	in	ADP
dpc-3912	50	24	adolescents	adolescent	NOUN
dpc-3912	50	25	.	.	PUNCT
dpc-3912	51	1	dermatol	dermatol	NOUN
dpc-3912	51	2	online	online	ADJ
dpc-3912	51	3	j.	j.	PROPN
dpc-3912	51	4	2007;13(4):4	2007;13(4):4	PROPN
dpc-3912	51	5	.	.	PUNCT
dpc-3912	52	1	pmid	pmid	NOUN
dpc-3912	52	2	:	:	PUNCT
dpc-3912	52	3	18319001	18319001	NUM
dpc-3912	52	4	.	.	PUNCT
dpc-3912	53	1	3	3	X
dpc-3912	53	2	.	.	X
dpc-3912	53	3	lacouture	lacouture	NOUN
dpc-3912	53	4	me	i	PRON
dpc-3912	53	5	,	,	PUNCT
dpc-3912	53	6	wainberg	wainberg	PROPN
dpc-3912	53	7	za	za	PROPN
dpc-3912	53	8	,	,	PUNCT
dpc-3912	53	9	patel	patel	PROPN
dpc-3912	53	10	ab	ab	PROPN
dpc-3912	53	11	,	,	PUNCT
dpc-3912	53	12	et	et	PROPN
dpc-3912	53	13	al	al	PROPN
dpc-3912	53	14	.	.	PUNCT
dpc-3912	54	1	reducing	reduce	VERB
dpc-3912	54	2	skin	skin	NOUN
dpc-3912	54	3	toxicities	toxicity	NOUN
dpc-3912	54	4	from	from	ADP
dpc-3912	54	5	egfr	egfr	ADJ
dpc-3912	54	6	inhibitors	inhibitor	NOUN
dpc-3912	54	7	with	with	ADP
dpc-3912	54	8	topical	topical	ADJ
dpc-3912	54	9	braf	braf	NOUN
dpc-3912	54	10	inhibitor	inhibitor	NOUN
dpc-3912	54	11	therapy	therapy	NOUN
dpc-3912	54	12	.	.	PUNCT
dpc-3912	55	1	cancer	cancer	NOUN
dpc-3912	55	2	discov	discov	NOUN
dpc-3912	55	3	.	.	PUNCT
dpc-3912	56	1	2021;11(9):2158	2021;11(9):2158	NUM
dpc-3912	56	2	-	-	SYM
dpc-3912	56	3	2167	2167	NUM
dpc-3912	56	4	.	.	PUNCT
dpc-3912	57	1	doi	doi	NOUN
dpc-3912	57	2	:	:	PUNCT
dpc-3912	57	3	10.1158/21598290.cd-20	10.1158/21598290.cd-20	NUM
dpc-3912	57	4	-	-	SYM
dpc-3912	57	5	1847	1847	NUM
dpc-3912	57	6	.	.	PUNCT
dpc-3912	58	1	pmid	pmid	NOUN
dpc-3912	58	2	:	:	PUNCT
dpc-3912	58	3	33910927	33910927	NUM
dpc-3912	58	4	.	.	PUNCT
dpc-3912	59	1	pmcid	pmcid	NOUN
dpc-3912	59	2	:	:	PUNCT
dpc-3912	59	3	pmc8418997	pmc8418997	NOUN
dpc-3912	59	4	.	.	PUNCT
dpc-3912	60	1	figure	figure	NOUN
dpc-3912	60	2	1	1	NUM
dpc-3912	60	3	.	.	PUNCT
dpc-3912	61	1	(	(	PUNCT
dpc-3912	61	2	a	a	X
dpc-3912	61	3	)	)	PUNCT
dpc-3912	61	4	clinical	clinical	ADJ
dpc-3912	61	5	picture	picture	NOUN
dpc-3912	61	6	of	of	ADP
dpc-3912	61	7	our	our	PRON
dpc-3912	61	8	patient	patient	NOUN
dpc-3912	61	9	,	,	PUNCT
dpc-3912	61	10	showing	show	VERB
dpc-3912	61	11	erythema	erythema	NOUN
dpc-3912	61	12	and	and	CCONJ
dpc-3912	61	13	scaling	scaling	NOUN
dpc-3912	61	14	.	.	PUNCT
dpc-3912	62	1	(	(	PUNCT
dpc-3912	62	2	b	b	X
dpc-3912	62	3	)	)	PUNCT
dpc-3912	62	4	trichoscopy	trichoscopy	NOUN
dpc-3912	62	5	of	of	ADP
dpc-3912	62	6	our	our	PRON
dpc-3912	62	7	patient	patient	NOUN
dpc-3912	62	8	:	:	PUNCT
dpc-3912	62	9	tufted	tufte	VERB
dpc-3912	62	10	hairs	hair	NOUN
dpc-3912	62	11	,	,	PUNCT
dpc-3912	62	12	perifollicular	perifollicular	ADJ
dpc-3912	62	13	erythema	erythema	NOUN
dpc-3912	62	14	and	and	CCONJ
dpc-3912	62	15	scaling	scaling	NOUN
dpc-3912	62	16	.	.	PUNCT
dpc-3912	63	1	figure	figure	NOUN
dpc-3912	63	2	2	2	NUM
dpc-3912	63	3	.	.	PUNCT
dpc-3912	63	4	transverse	transverse	NOUN
dpc-3912	63	5	section	section	NOUN
dpc-3912	63	6	of	of	ADP
dpc-3912	63	7	one	one	NUM
dpc-3912	63	8	biopsy	biopsy	NOUN
dpc-3912	63	9	from	from	ADP
dpc-3912	63	10	scalp	scalp	NOUN
dpc-3912	63	11	showing	show	VERB
dpc-3912	63	12	overall	overall	ADJ
dpc-3912	63	13	reduction	reduction	NOUN
dpc-3912	63	14	in	in	ADP
dpc-3912	63	15	hair	hair	NOUN
dpc-3912	63	16	follicle	follicle	NOUN
dpc-3912	63	17	number	number	NOUN
dpc-3912	63	18	(	(	PUNCT
dpc-3912	63	19	a	a	X
dpc-3912	63	20	)	)	PUNCT
dpc-3912	63	21	with	with	ADP
dpc-3912	63	22	perifollicular	perifollicular	ADJ
dpc-3912	63	23	and	and	CCONJ
dpc-3912	63	24	perivascular	perivascular	ADJ
dpc-3912	63	25	predominantly	predominantly	ADV
dpc-3912	63	26	neutrophilic	neutrophilic	ADJ
dpc-3912	63	27	inflammatory	inflammatory	ADJ
dpc-3912	63	28	infiltrate	infiltrate	NOUN
dpc-3912	63	29	and	and	CCONJ
dpc-3912	63	30	fibrosis	fibrosis	NOUN
dpc-3912	63	31	(	(	PUNCT
dpc-3912	63	32	b	b	NOUN
dpc-3912	63	33	)	)	PUNCT
dpc-3912	63	34	.	.	PUNCT
dpc-3912	64	1	(	(	PUNCT
dpc-3912	64	2	h&e	h&e	PROPN
dpc-3912	64	3	original	original	ADJ
dpc-3912	64	4	magnifications	magnification	NOUN
dpc-3912	64	5	:	:	PUNCT
dpc-3912	64	6	a	a	X
dpc-3912	64	7	,	,	PUNCT
dpc-3912	64	8	x50	x50	NUM
dpc-3912	64	9	;	;	PUNCT
dpc-3912	64	10	b	b	X
dpc-3912	64	11	,	,	PUNCT
dpc-3912	64	12	x120	x120	PROPN
dpc-3912	64	13	.	.	PUNCT
dpc-3912	64	14	)	)	PUNCT
dpc-3912	64	15	.	.	PUNCT
dpc-3912	65	1	research	research	NOUN
dpc-3912	65	2	letter	letter	NOUN
dpc-3912	65	3	|	|	ADV
dpc-3912	65	4	dermatol	dermatol	ADJ
dpc-3912	65	5	pract	pract	NOUN
dpc-3912	65	6	concept	concept	NOUN
dpc-3912	65	7	.	.	PUNCT
dpc-3912	66	1	2024;14(3):e2024161	2024;14(3):e2024161	NUM
dpc-3912	66	2	3	3	NUM
dpc-3912	66	3	4	4	NUM
dpc-3912	66	4	.	.	PUNCT
dpc-3912	67	1	dervout	dervout	NOUN
dpc-3912	67	2	c	c	X
dpc-3912	67	3	,	,	PUNCT
dpc-3912	67	4	chiappa	chiappa	VERB
dpc-3912	67	5	a	a	PROPN
dpc-3912	67	6	-	-	PUNCT
dpc-3912	67	7	m	m	NOUN
dpc-3912	67	8	,	,	PUNCT
dpc-3912	67	9	fleuret	fleuret	ADJ
dpc-3912	67	10	c	c	NOUN
dpc-3912	67	11	,	,	PUNCT
dpc-3912	67	12	plantin	plantin	PROPN
dpc-3912	67	13	p	p	PROPN
dpc-3912	67	14	,	,	PUNCT
dpc-3912	67	15	acquitter	acquitter	NOUN
dpc-3912	67	16	m.	m.	NOUN
dpc-3912	67	17	alopécie	alopécie	PROPN
dpc-3912	67	18	cicatricielle	cicatricielle	VERB
dpc-3912	67	19	à	à	X
dpc-3912	67	20	type	type	NOUN
dpc-3912	67	21	de	de	ADP
dpc-3912	67	22	folliculite	folliculite	NOUN
dpc-3912	67	23	décalvante	décalvante	NOUN
dpc-3912	67	24	induite	induite	ADP
dpc-3912	67	25	par	par	PROPN
dpc-3912	67	26	l’erlotinib	l’erlotinib	PROPN
dpc-3912	67	27	.	.	PUNCT
dpc-3912	68	1	ann	ann	PROPN
dpc-3912	68	2	dermatol	dermatol	PROPN
dpc-3912	68	3	venereol	venereol	NOUN
dpc-3912	68	4	.	.	PUNCT
dpc-3912	69	1	2020;147(12):848	2020;147(12):848	X
dpc-3912	69	2	-	-	SYM
dpc-3912	69	3	852	852	NUM
dpc-3912	69	4	.	.	PUNCT
dpc-3912	70	1	doi	doi	NOUN
dpc-3912	70	2	:	:	PUNCT
dpc-3912	70	3	10.1016	10.1016	NUM
dpc-3912	70	4	/	/	SYM
dpc-3912	70	5	j.annder.2020.08.043	j.annder.2020.08.043	PROPN
dpc-3912	70	6	.	.	PUNCT
dpc-3912	71	1	pmid	pmid	NOUN
dpc-3912	71	2	:	:	PUNCT
dpc-3912	71	3	33097309	33097309	NUM
dpc-3912	71	4	.	.	PUNCT
dpc-3912	72	1	5	5	X
dpc-3912	72	2	.	.	X
dpc-3912	72	3	osimertinib	osimertinib	NOUN
dpc-3912	72	4	tablets	tablet	NOUN
dpc-3912	72	5	.	.	PUNCT
dpc-3912	73	1	united	united	PROPN
dpc-3912	73	2	states	states	PROPN
dpc-3912	73	3	prescribing	prescribe	VERB
dpc-3912	73	4	information	information	NOUN
dpc-3912	73	5	.	.	PUNCT
dpc-3912	74	1	us	us	PROPN
dpc-3912	74	2	national	national	PROPN
dpc-3912	74	3	library	library	NOUN
dpc-3912	74	4	of	of	ADP
dpc-3912	74	5	medicine	medicine	NOUN
dpc-3912	74	6	.	.	PUNCT
dpc-3912	75	1	available	available	ADJ
dpc-3912	75	2	at	at	ADP
dpc-3912	75	3	:	:	PUNCT
dpc-3912	75	4	http://www	http://www	PROPN
dpc-3912	75	5	.	.	PROPN
dpc-3912	75	6	accessdata.fda.gov/drugsatfda_docs/label/2018/208065s008lbl	accessdata.fda.gov/drugsatfda_docs/label/2018/208065s008lbl	PROPN
dpc-3912	75	7	.	.	PUNCT
dpc-3912	75	8	pdf	pdf	NOUN
dpc-3912	75	9	(	(	PUNCT
dpc-3912	75	10	accessed	access	VERB
dpc-3912	75	11	on	on	ADP
dpc-3912	75	12	august	august	PROPN
dpc-3912	75	13	26	26	NUM
dpc-3912	75	14	,	,	PUNCT
dpc-3912	75	15	2019	2019	NUM
dpc-3912	75	16	)	)	PUNCT
dpc-3912	75	17	.	.	PUNCT
dpc-3912	76	1	6	6	X
dpc-3912	76	2	.	.	X
dpc-3912	76	3	philpott	philpott	PROPN
dpc-3912	76	4	mp	mp	PROPN
dpc-3912	76	5	,	,	PUNCT
dpc-3912	76	6	kealey	kealey	NOUN
dpc-3912	76	7	t.	t.	NOUN
dpc-3912	76	8	effects	effect	NOUN
dpc-3912	76	9	of	of	ADP
dpc-3912	76	10	egf	egf	PROPN
dpc-3912	76	11	on	on	ADP
dpc-3912	76	12	the	the	DET
dpc-3912	76	13	morphology	morphology	NOUN
dpc-3912	76	14	and	and	CCONJ
dpc-3912	76	15	patterns	pattern	NOUN
dpc-3912	76	16	of	of	ADP
dpc-3912	76	17	dna	dna	PROPN
dpc-3912	76	18	synthesis	synthesis	NOUN
dpc-3912	76	19	in	in	ADP
dpc-3912	76	20	isolated	isolated	ADJ
dpc-3912	76	21	human	human	ADJ
dpc-3912	76	22	hair	hair	NOUN
dpc-3912	76	23	follicles	follicle	NOUN
dpc-3912	76	24	.	.	PUNCT
dpc-3912	77	1	j	j	PROPN
dpc-3912	77	2	invest	invest	VERB
dpc-3912	77	3	dermatol	dermatol	NOUN
dpc-3912	77	4	.	.	PUNCT
dpc-3912	78	1	1994	1994	NUM
dpc-3912	78	2	feb;102(2):186	feb;102(2):186	PROPN
dpc-3912	78	3	-	-	PUNCT
dpc-3912	78	4	91	91	NUM
dpc-3912	78	5	.	.	PUNCT
dpc-3912	79	1	doi	doi	NOUN
dpc-3912	79	2	:	:	PUNCT
dpc-3912	80	1	10.1111/15231747.ep12371760	10.1111/15231747.ep12371760	NUM
dpc-3912	80	2	.	.	PUNCT
dpc-3912	81	1	pmid	pmid	NOUN
dpc-3912	81	2	:	:	PUNCT
dpc-3912	81	3	8106747	8106747	NUM
dpc-3912	81	4	.	.	PUNCT